# FDA WARNING_LETTER - for our vets llc  - October 08, 2020

Source: https://www.keypedia.com/records/warning_letter/for-our-vets-llc/1a4c83ed-3c3f-4322-92ff-39f12f8c286a

> FDA WARNING_LETTER for for our vets llc  on October 08, 2020. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: for our vets llc 
- Inspection Date: 2020-10-08
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research
- Summary: On October 16, 2020, the FDA and FTC issued a Warning Letter to Patriot Supreme regarding the sale of unapproved and misbranded CBD products claiming to mitigate, prevent, treat, diagnose, or cure COVID-19. The agencies reviewed the company's website (https://patriotsupreme.com) and social media pages (Facebook, Instagram) on October 5 and 8, 2020.

The FDA determined these CBD products are unapproved new drugs under section 505(a) of the FD&C Act, 21 U.S.C. § 355(a), and misbranded drugs under section 502, 21 U.S.C. § 352. The introduction of these products into interstate commerce is prohibited by sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d). Examples of violative claims include statements linking CBD to treating ARDS, shortness of breath, and lung inflammation caused by COVID-19.

The letter requires immediate action to cease the sale of these products. Patriot Supreme must email COVID-19-Task-Force-CDER@fda.hhs.gov within 48 hours, detailing corrective steps, recurrence prevention, and supporting documentation. Failure to comply may result

## Related Officers

- [Director](https://www.keypedia.com/people/donald-d-ashley/060f0dda-e6e8-4f9c-97e7-f540d523d902)
- [Associate Director](https://www.keypedia.com/people/serena-viswanathan/7d1b292d-1f22-42ff-8452-0bc9673b8326)

Company: https://www.keypedia.com/companies/for-our-vets-llc/e5de13c0-4e9a-462d-89d4-cd50aaaa5963

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c